[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-271608-105":59,"doc-detail-271608-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","emerging-infectious-diseases-journal-report-2024","Emerging Infectious Diseases - Journal Report 2024","","Emerging Infectious Diseases (EID) Journal Report 2024 outlines the journal’s mission and measurable reach in advancing open-access infectious disease research. It highlights editorial leadership, volunteer Associate Editors and board members supporting rigorous peer review, and acknowledges reviewers’ timely evaluations during 2024. The report summarizes audiences, submission and acceptance rates, publication volume, circulation metrics, and EID’s essential role in supporting preparedness, informing public health strategies, and protecting communities from emerging and reemerging threats.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/emerging-infectious-diseases-journal-report-2024/271608/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/emerging-infectious-diseases-journal-report-2024/271608.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-15",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",17,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the purpose of the Emerging Infectious Diseases (EID) journal report?","Question",{"text":113,"@type":114},"The report communicates EID’s role, progress, and impact, including editorial support, peer review standards, audiences, and key circulation and publication metrics for 2024.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How many submissions does EID receive and what portion is accepted?",{"text":118,"@type":114},"EID typically receives about 2,000 manuscripts per year, and approximately 25% of submissions are accepted.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is EID’s open-access model considered a distinguishing feature?",{"text":122,"@type":114},"EID is free and open access for readers and does not charge authors publication fees, removing barriers to accessing research and supporting timely evidence for public health decisions.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},271608,1789460974,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":130,"read_time":46,"preview_page_count":4},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","®  \n2024 JOURNAL REPORT   \nMessage from the Editor-in-Chief   \nEmerging Infectious Diseases (EID) celebrates its 30th anniversary in 2025, marking three decades of publishing open-access articles that provide critical research and insights, without charges to readers or authors. The journal occupies a unique niche in infectious disease public health, identifying clinical, laboratory, zoonotic, and environmental threats by emerging and reemerging pathogens. The journal attracts submissions both from leading scientists and public health specialists and from researchers and health practitioners in places around the world where outbreaks may be occurring.  \nSince its inception in 1995, Emerging Infectious Diseases has published more than 13,500 articles that have been cited more than 600,000 times, and its contents have been accessed more than 54 million times on PubMed Central since 2009. Those metrics underscore how valuable the journal’s content is for its readers.  \nEmerging Infectious Diseases has been able to sustain its success in large measure because of the dedication of its highly qualified Associate Editors and Editorial Board members, who volunteer their expertise to ensure rigorous peer review and high standards for published content. Their commitment, together with the efforts of the journal’s hard-working staff and support from the Centers for Disease Control and Prevention, keeps EID relevant and impactful for infectious disease specialists and public health officials in the United States and worldwide.  \nThank you for your support of the journal these past 30 years and beyond. If you have ideas or feedback about this report or about the journal, please let us know.  \nSincerely,  \nD. Peter Drotman  \nEditor-in Chief, Emerging Infectious Diseases  \n2024 Reviewers  \nEmerging Infectious Diseases thanks its reviewers for their support through thoughtful, thorough, and timely reviews in 2024.  \nSee the list of 2024 reviewers at [https://wwwnc.cdc.gov/eid/reviewers/2024](https://wwwnc.cdc.gov/eid/reviewers/2024)  \n2  \nEmerging Infectious Diseases’ Audiences  \nInfectious diseases and related sciences professionals  \nState and local  \npublic health officials  \nResearchers in academia  \nIndustry professionals  \nEconomists and social scientists  \nSubmissionsand Acceptance  \nEID typically receives about 2,000 manuscripts per year from authors around the world. Approximately 25% of submissions are accepted.  \n2024 Circulation  \n>3.3 million website visits  \n>6.3 million  \nemails to subscribers 2,717 pages published 2,315 appendix pages published  \nSince 1995, Emerging Infectious Diseases has been at the forefront of public health as an open-access, online scientific journal dedicated to providing critical research on new and reemerging infectious diseases.  \nEID serves as an essential resource not only for scientists investigating potential health threats but also for the professionals who respond to these challenges in communities everywhere. By delivering valuable insights into the factors that contribute to disease emergence, control, and prevention, EID plays a crucial role in safeguarding public health.  \nThe research published in EID  \n• Enhances domestic and global preparedness  \n• Informs public health strategies  \n• Protects people from infectious disease threats  \nThrough its commitment to accessible knowledge and rigorous scientific inquiry, EID empowers public health professionals to make informed decisions that ultimately protect health.  \nWhat are emerging infectious diseases?  \nInfectious diseases that have had increased incidence in humans during the past three decades or that threaten to increase in the near future have been defined as “emerging.”  \nA Vital Resource: EID’s Essential Role in Protecting Health  \nEmerging Infectious Diseases • Journal Report 2024 3  \nFree, Reliable, and Unbiased: How EID’s Open Access Sets It Apart  \nOne of the standout features of Emerging Infectious Diseases journal is its compl","cbCaicK8B04fsqVU","https://ap.wps.com/l/cbCaicK8B04fsqVU","pdf",1215024,"English","# Message from the Editor-in-Chief\n# 2024 Reviewers\n# Emerging Infectious Diseases’ Audiences\n# Submissions and Acceptance\n# 2024 Circulation\n# The Research Published in EID\n# What Are Emerging Infectious Diseases?\n# A Vital Resource: EID’s Essential Role in Protecting Health\n# Free, Reliable, and Unbiased: How EID’s Open Access Sets It Apart","[{\"question\":\"What is the purpose of the Emerging Infectious Diseases (EID) journal report?\",\"answer\":\"The report communicates EID’s role, progress, and impact, including editorial support, peer review standards, audiences, and key circulation and publication metrics for 2024.\"},{\"question\":\"How many submissions does EID receive and what portion is accepted?\",\"answer\":\"EID typically receives about 2,000 manuscripts per year, and approximately 25% of submissions are accepted.\"},{\"question\":\"Why is EID’s open-access model considered a distinguishing feature?\",\"answer\":\"EID is free and open access for readers and does not charge authors publication fees, removing barriers to accessing research and supporting timely evidence for public health decisions.\"}]","Emerging Infectious Diseases - Journal Report 2024 | PDF"]